210 related articles for article (PubMed ID: 1752539)
1. [Chronic myeloid leukemia: progress and prospects].
Baccarani M; Russo D; Fanin R
Haematologica; 1991 Jun; 76 Suppl 3():40-5. PubMed ID: 1752539
[No Abstract] [Full Text] [Related]
2. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
[No Abstract] [Full Text] [Related]
3. [Chronic myeloid leukemia: a decade of progress].
Cervantes F
Med Clin (Barc); 1990 Jan; 94(1):27-35. PubMed ID: 1692385
[No Abstract] [Full Text] [Related]
4. Chronic myeloid leukemia.
Sawyers CL
N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
[No Abstract] [Full Text] [Related]
5. Chronic myeloid leukemia. A perspective of the clinical and biologic issues of the chronic phase.
Silver RT
Hematol Oncol Clin North Am; 1990 Apr; 4(2):319-35. PubMed ID: 2182594
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of chronic myeloid leukemia].
Freund M
Internist (Berl); 1993 Jun; 34(6):542-9. PubMed ID: 8335444
[No Abstract] [Full Text] [Related]
7. [Interferon and chronic myeloid leukemia].
Steegmann JL; Pérez Sánchez M; Fernández-Rañada JM
Sangre (Barc); 1990 Jun; 35(3):213-7. PubMed ID: 2204124
[No Abstract] [Full Text] [Related]
8. [Changing concept of conventional therapy in chronic myelogenous leukemia].
Ueda R
Rinsho Ketsueki; 2000 Apr; 41(4):268-71. PubMed ID: 10846452
[No Abstract] [Full Text] [Related]
9. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
10. Chronic myelogenous leukemia--update and future directions.
Kantarjian HM; Deisseroth A; Talpaz M
Rev Invest Clin; 1994 Apr; Suppl():118-24. PubMed ID: 7886295
[No Abstract] [Full Text] [Related]
11. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of blast crisis of chronic myeloid leukemia].
Kotlarek-Haus S
Acta Haematol Pol; 1992; 23(2 Suppl 1):23-9. PubMed ID: 1488869
[TBL] [Abstract][Full Text] [Related]
13. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
[No Abstract] [Full Text] [Related]
14. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
Yao B; Guo M; Pian H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetics of chronic myeloid leukaemia.
Chase A; Huntly BJ; Cross NC
Best Pract Res Clin Haematol; 2001 Sep; 14(3):553-71. PubMed ID: 11640869
[TBL] [Abstract][Full Text] [Related]
17. Chronic myelogenous leukemia: state of the art.
Polli EE; Pozzoli E; Annaloro C
Ann Ital Med Int; 1991; 6(4 Pt 2):491-7. PubMed ID: 1840816
[TBL] [Abstract][Full Text] [Related]
18. [Chronic myeloid leukemia. Current strategies in diagnosis, therapy and follow-up].
Hochhaus A; Hehlmann R
Internist (Berl); 1996 Oct; 37(10):1013-21. PubMed ID: 9019445
[No Abstract] [Full Text] [Related]
19. [Progress in the field of hematology in the last 100 years: Medical history of chronic myelogenous leukemia].
Tomonaga M
Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2090-4. PubMed ID: 12187683
[No Abstract] [Full Text] [Related]
20. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
